Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HSBC chair Mark Tucker to join AIA as search for successor continues

(Sharecast News) - HSBC has confirmed that its departing chair Mark Tucker is set to leave the bank in three months without the board having yet announced a successor. Tucker, who announced last month his intention to retire before the end of the year, has now been recruited as the non-executive chair of AIA and will join the insurance giant on 1 October.

Accordingly, he will step down as HSBC group chair with effect from 30 September, after eight years with the company.

Independent non-executive director Brendan Nelson, who is chair of the group audit committee, is to step in as interim group chair once Tucker leaves.

HSBC said the succession process to select a permanent replacement is "ongoing" and the bank will provide updates "in due course".

"The Nomination and Corporate Governance Committee continues to make progress on the succession process for the next HSBC Group Chair," said Ann Godbehere, HSBC's senior independent director who is leading the search.

"Our focus is on securing the best candidate to lead the Board and wider Group over the next phase of our growth and development," she said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.